US2023017195A1PendingUtilityA1
Compositions and methods of treating viral infections
Est. expiryJan 28, 2029(~2.5 yrs left)· nominal 20-yr term from priority
Inventors:Jan Remmereit
A23V 2250/5438A61K 31/715A23L 33/105A61K 31/7012A23V 2200/332A23V 2200/33A61K 36/87A23L 29/256A61K 36/481A61K 36/03A61P 17/00A23V 2200/30A61K 2300/00A23V 2002/00A23V 2200/318A61K 31/737A61P 3/04A61K 31/727A23V 2200/31A23V 2250/51A23V 2250/2116A61P 43/00A23L 33/40A61K 31/352A61K 31/05
81
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled)
20 . A composition comprising:
a first component of from 0.1 g and 10.0 g of sialic acid selected form the group consisting of N-acetylneuraminic acid (NANA), n-glycolylneraminic acid (NGNA), and 2-keto-3-deoxynonic acid (KDN) and a at least a second component selected from the group consisting of from 1 to 100 mg resveratrol, from 2 to 20 grams fucoidan and from 0.1 to 10 grams astragalus polysaccharide (APS).
21 . The composition of claim 20 , wherein the sialic acid is NANA.
22 . The composition of claim 20 , wherein the sialic acid is NGNA.
23 . The composition of claim 20 wherein the sialic acid is KDN.
24 . The composition of claim 20 , wherein the at least a second component is from 1 to 100 mg resveratrol.
25 . The composition of claim 20 , wherein the at least a second component is from 2 to 20 grams fucoidan.
26 . The composition of claim 20 , wherein the at least second component is from 0.1 to 10 grams astragalus polysaccharide (APS).
27 . The composition of claim 20 , wherein the at least second component is a combination of from 2 to 20 grams fucoidan and from 0.1 to 10 grams astragalus polysaccharide (APS).
28 . The composition of claim 20 , wherein the at least second component is a combination of from 1 to 100 mg resveratrol and from 2 to 20 grams fucoidan.
29 . The composition of claim 20 , wherein the at least second component is a combination of from 1 to 100 mg resveratrol and from 0.1 to 10 grams astragalus polysaccharide (APS).
30 . The composition of claim 20 , wherein the at least second component is a combination of from 1 to 100 mg resveratrol, from 0.1 to 10 grams astragalus polysaccharide (APS), and from 2 to 20 grams fucoidan.Join the waitlist — get patent alerts
Track US2023017195A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.